Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TearLab Corp (OTCQB:TEAR)

0.40
Delayed Data
As of 3:22pm ET
 -0.01 / -2.44%
Today’s Change
0.37
Today|||52-Week Range
7.50
-92.31%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$2.4M

Company Description

TearLab Corp. engages in the development and marketing of lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by testing disease markers in tears at the point-of-care. It also intends to measure the osmolarity of human tears to aid in the diagnosis of dry eye disease in patients suspected of having dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in San Diego, CA.

Contact Information

TearLab Corp.
9980 Huennekens Street
San Diego California 92121
P:(855) 832-7522
Investor Relations:

Employees

Shareholders

Individual stakeholders6.98%
Mutual fund holders6.72%
Other institutional0.92%

Top Executives

Joseph JensenChief Executive Officer & Director
Wes BrazellCFO & Principal Accounting Officer
Benjamin D. SullivanChief Scientific Officer
Michael A. LempChief Medical Officer
Sam FakhouryVP-Compliance, Quality & Supply Chain